Skip to main content

Liver and bile duct.

10 Phase 1 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Liver and bile duct10 studies

Hepatocellular CarcinomaPhase 1NCT05003895

CAR-T cell

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

National Cancer Institute (NCI)Open the brief

Liver CancerPhase 1NCT04715191

CARE T cells

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Baylor College of MedicineOpen the brief

Hepatocellular Carcinoma (HCC)Phase 1NCT07075120Papers

Ipilimumab and Nivolumab

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

University of HawaiiOpen the brief

Untreated Advanced Biliary Tract CancerPhase 1NCT07107750

Emavusertib + Gemcitabine, Cisplatin and Durvalumab

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Washington University School of MedicineOpen the brief

Fibrolamellar Hepatocellular Carcinoma (FLC)Phase 1NCT04248569Papers

DNAJB1-PRKACA peptide vaccine

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOpen the brief

Clinical trials: Phase 1 and Phase 2, explained